ReviewExperimental & molecular medicine2019

Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers.

Flavia Fondevila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.